Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CADL

Candel Therapeutics, Inc.

CIK 0001841387 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$13.13
↑ 0.78 (6.32%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$1.00B
P/E Ratio
-11.35
EPS
-0.72
Dividend Yield
Not covered
52W Position
93%
Beta
1.92

Valuation multiples

Fwd P/E
43.48
PEG
Not covered
P/B
7.97
P/S
Not covered
EV/Revenue
Not covered
ROE
-70.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$4.35$13.82

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$38.18M
Total Assets
$125.19M
Free Cash Flow
-$38.90M

Recent news